Ulcerative Colitis Clinical Trials near Dallas, TX
18 studies for Ulcerative Colitis are recruiting at 38 sites within 50 miles of Dallas, Texas, according to ClinicalTrials.gov data processed .
Distances are city-level approximations. See all Ulcerative Colitis trials in the US or all trials near Dallas.
Recruiting now
Ulcerative Colitis studies enrolling near Dallas
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
NCT03816345
- Phase 1
- Ages 18 years and older
- Sex: All
Nearest sites: UT Southwestern Simmons Cancer Center - RedBird (Dallas, TX); UT Southwestern/Simmons Cancer Center-Dallas (Dallas, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 4 sites within 50 mi
- A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
NCT06095128
- Phase 4
- Ages 18 to 65 years
- Sex: All
Nearest sites: GI Alliance - Digestive Health Associates of Texas (Dallas, TX); Texas Digestive Disease Consultants (TDDC), Southlake (Southlake, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
NCT07113522
- Phase 2
- Ages 18 to 80 years
- Sex: All
Nearest sites: Mirador Therapeutics Selected Site (Dallas, TX); Mirador Therapeutics Selected Site (Garland, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07184996
- Phase 3
- Ages 16 to 80 years
- Sex: All
Nearest sites: The University of Texas Southwestern Medical Center - Site Number: 8400098 (Dallas, TX); Texas Digestive Disease Consultants, PLLC. dba GI Alliance - Southlake - Site Number: 8400101 (Southlake, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
NCT05230173
- Interventional
- Ages 18 years and older
- Sex: All
Nearest site: University of Texas Southwestern (Dallas, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
NCT07071519
- Phase 3
- Ages 2 to 17 years
- Sex: All
Nearest site: University of Texas - Southwestern Medical Center /ID# 271835 (Dallas, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
NCT07196748
- Phase 3
- Ages 12 years and older
- Sex: All
Nearest sites: DFW Clinical Trials (Carrollton, TX); GI Alliance Southlake (Southlake, TX)
- Distance to nearest recruiting site
- ~13 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
NCT07697456
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest sites: GI Alliance -Garland /ID# 284253 (Garland, TX); Texas Digestive Disease Consultants - Southlake /ID# 283931 (Southlake, TX)
- Distance to nearest recruiting site
- ~13 mi (city-level)
- Recruiting sites
- 4 sites within 50 mi
- LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044
- Phase 2
- Ages 18 to 80 years
- Sex: All
Nearest sites: GI Alliance - Garland (Garland, TX); GI Alliance: Mansfield (Mansfield, TX)
- Distance to nearest recruiting site
- ~13 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07845487
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest sites: Site US-024 (Garland, TX); Site US-001 (Southlake, TX)
- Distance to nearest recruiting site
- ~13 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
NCT06619990
- Phase 1/2
- Ages 18 to 75 years
- Sex: All
- Accepts healthy volunteers
Nearest sites: Xencor Investigative Site (Garland, TX); Xencor Investigative Site (Denton, TX)
- Distance to nearest recruiting site
- ~13 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
NCT06651281
- Phase 3
- Ages Any age
- Sex: All
Nearest sites: GI Alliance - Digestive Health Associates of Texas - DHAT ( Site 0290) (Garland, TX); GI Alliance - Southlake ( Site 0298) (Southlake, TX)
- Distance to nearest recruiting site
- ~13 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest sites: Site 005 (Garland, TX); Site 008 (Southlake, TX)
- Distance to nearest recruiting site
- ~13 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
NCT07186101
- Phase 2
- Ages 18 to 80 years
- Sex: All
Nearest sites: GI Alliance - Garland (Garland, TX); GI Alliance - Fort Worth (Fort Worth, TX)
- Distance to nearest recruiting site
- ~13 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
NCT06398626
- Observational
- Ages 18 to 64 years
- Sex: All
Nearest site: GI Alliance Research (Southlake, TX)
- Distance to nearest recruiting site
- ~22 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07185009
- Phase 3
- Ages 16 to 80 years
- Sex: All
Nearest site: Texas Digestive Disease Consultants, PLLC. dba GI Alliance - Southlake - Corporate Office - Site Number: 8400101 (Southlake, TX)
- Distance to nearest recruiting site
- ~22 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
NCT04844606
- Phase 3
- Ages 2 to 19 years
- Sex: All
Nearest site: Cook Children's Medical Center (Fort Worth, TX)
- Distance to nearest recruiting site
- ~30 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
NCT06663332
- Phase 3
- Ages 3 years and older
- Sex: All
Nearest site: Cook Childrens Medical Center (Fort Worth, TX)
- Distance to nearest recruiting site
- ~30 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
FAQ
Common questions
What is a clinical trial?
Is there compensation for joining an Ulcerative Colitis clinical trial?
How do I check if I'm eligible?
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.